281 related articles for article (PubMed ID: 14633118)
1. Myeloperoxidase in kidney disease.
Malle E; Buch T; Grone HJ
Kidney Int; 2003 Dec; 64(6):1956-67. PubMed ID: 14633118
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of hypochlorite-modified proteins in glomeruli of human membranous glomerulonephritis.
Gröne HJ; Gröne EF; Malle E
Lab Invest; 2002 Jan; 82(1):5-14. PubMed ID: 11796821
[TBL] [Abstract][Full Text] [Related]
3. Immunological evidence for hypochlorite-modified proteins in human kidney.
Malle E; Woenckhaus C; Waeg G; Esterbauer H; Gröne EF; Gröne HJ
Am J Pathol; 1997 Feb; 150(2):603-15. PubMed ID: 9033274
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase-dependent generation of hypochlorite-modified proteins in human placental tissues during normal pregnancy.
Hammer A; Desoye G; Dohr G; Sattler W; Malle E
Lab Invest; 2001 Apr; 81(4):543-54. PubMed ID: 11304574
[TBL] [Abstract][Full Text] [Related]
5. Chlorination and oxidation of the extracellular matrix protein laminin and basement membrane extracts by hypochlorous acid and myeloperoxidase.
Nybo T; Dieterich S; Gamon LF; Chuang CY; Hammer A; Hoefler G; Malle E; Rogowska-Wrzesinska A; Davies MJ
Redox Biol; 2019 Jan; 20():496-513. PubMed ID: 30476874
[TBL] [Abstract][Full Text] [Related]
6. Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide.
Sampson JB; Ye Y; Rosen H; Beckman JS
Arch Biochem Biophys; 1998 Aug; 356(2):207-13. PubMed ID: 9705211
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins.
Malle E; Waeg G; Schreiber R; Gröne EF; Sattler W; Gröne HJ
Eur J Biochem; 2000 Jul; 267(14):4495-503. PubMed ID: 10880973
[TBL] [Abstract][Full Text] [Related]
8. Hypochlorite-modified (lipo)proteins are present in rabbit lesions in response to dietary cholesterol.
Malle E; Wäg G; Thiery J; Sattler W; Gröne HJ
Biochem Biophys Res Commun; 2001 Dec; 289(4):894-900. PubMed ID: 11735131
[TBL] [Abstract][Full Text] [Related]
9. Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypochlorous and hypothiocyanous acids.
Pattison DI; Davies MJ; Hawkins CL
Free Radic Res; 2012 Aug; 46(8):975-95. PubMed ID: 22348603
[TBL] [Abstract][Full Text] [Related]
10. The free amino acid tyrosine enhances the chlorinating activity of human myeloperoxidase.
Vlasova II; Sokolov AV; Arnhold J
J Inorg Biochem; 2012 Jan; 106(1):76-83. PubMed ID: 22112843
[TBL] [Abstract][Full Text] [Related]
11. Myeloperoxidase amplified high glucose-induced endothelial dysfunction in vasculature: Role of NADPH oxidase and hypochlorous acid.
Tian R; Ding Y; Peng YY; Lu N
Biochem Biophys Res Commun; 2017 Mar; 484(3):572-578. PubMed ID: 28131839
[TBL] [Abstract][Full Text] [Related]
12. The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids.
Spickett CM; Jerlich A; Panasenko OM; Arnhold J; Pitt AR; Stelmaszyńska T; Schaur RJ
Acta Biochim Pol; 2000; 47(4):889-99. PubMed ID: 11996112
[TBL] [Abstract][Full Text] [Related]
13. Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and HOSCN with low-density lipoprotein (LDL): Implications for foam cell formation in atherosclerosis.
Ismael FO; Proudfoot JM; Brown BE; van Reyk DM; Croft KD; Davies MJ; Hawkins CL
Arch Biochem Biophys; 2015 May; 573():40-51. PubMed ID: 25795019
[TBL] [Abstract][Full Text] [Related]
14. Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium.
Porubsky S; Schmid H; Bonrouhi M; Kretzler M; Malle E; Nelson PJ; Gröne HJ
Am J Pathol; 2004 Jun; 164(6):2175-87. PubMed ID: 15161651
[TBL] [Abstract][Full Text] [Related]
15. Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro.
Marsche G; Furtmüller PG; Obinger C; Sattler W; Malle E
Cardiovasc Res; 2008 Jul; 79(1):187-94. PubMed ID: 18296711
[TBL] [Abstract][Full Text] [Related]
16. Myeloperoxidase acts as a source of free iron during steady-state catalysis by a feedback inhibitory pathway.
Maitra D; Shaeib F; Abdulhamid I; Abdulridha RM; Saed GM; Diamond MP; Pennathur S; Abu-Soud HM
Free Radic Biol Med; 2013 Oct; 63():90-8. PubMed ID: 23624305
[TBL] [Abstract][Full Text] [Related]
17. Morphologic correlates of glomerular oxidant injury induced by the myeloperoxidase-hydrogen peroxide-halide system of the neutrophil.
Johnson RJ; Guggenheim SJ; Klebanoff SJ; Ochi RF; Wass A; Baker P; Schulze M; Couser WG
Lab Invest; 1988 Mar; 58(3):294-301. PubMed ID: 2831432
[TBL] [Abstract][Full Text] [Related]
18. Melatonin prevents myeloperoxidase heme destruction and the generation of free iron mediated by self-generated hypochlorous acid.
Shaeib F; Khan SN; Ali I; Najafi T; Maitra D; Abdulhamid I; Saed GM; Pennathur S; Abu-Soud HM
PLoS One; 2015; 10(3):e0120737. PubMed ID: 25835505
[TBL] [Abstract][Full Text] [Related]
19. Targeted subendothelial matrix oxidation by myeloperoxidase triggers myosin II-dependent de-adhesion and alters signaling in endothelial cells.
Rees MD; Dang L; Thai T; Owen DM; Malle E; Thomas SR
Free Radic Biol Med; 2012 Dec; 53(12):2344-56. PubMed ID: 23059132
[TBL] [Abstract][Full Text] [Related]
20. The reactivity of myeloperoxidase compound I formed with hypochlorous acid.
Furtmüller PG; Burner U; Jantschko W; Regelsberger G; Obinger C
Redox Rep; 2000; 5(4):173-8. PubMed ID: 10994870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
